Kate D. Lynch

536 citations
23 papers · 123 indexed · h-index 5

Kate D. Lynch

15 papers receiving 121 citations

Peers

Kate D. Lynch
Comparison fields: 5 of 33
  • Hepatology 56
  • Epidemiology 70
  • Pharmacology 11
  • Oncology 34
  • Surgery 34
Replace Waleed Fateen with:
Waleed Fateen United Kingdom
Rika Iwata Switzerland
Martina Gagliardi Italy
Chengxiao Yu China
Takahiro Ozutsumi Japan
Kai‐Chi Chang Taiwan
Rebecca Saich United Kingdom
Sandra Saldana Mexico
Stefan Lueth Germany
Sui‐Weng Wong Malaysia
Kate D. Lynch relative to Waleed Fateen United Kingdom Waleed Fateen's profile →
Citations per field
00.5×1.5×2.3×
Waleed Fateen · 1×
Citations per year

Countries citing papers authored by Kate D. Lynch

Since Specialization
Citations

This map shows the geographic impact of Kate D. Lynch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kate D. Lynch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kate D. Lynch more than expected).

Fields of papers citing papers by Kate D. Lynch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kate D. Lynch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kate D. Lynch. The network helps show where Kate D. Lynch may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Kate D. Lynch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kate D. Lynch Line = papers co-authored together Kate D. Lynch links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20250
3 20251
4 20250
5 20240
6 20243
7 20240
8 20241
9 20240
10 20241
11 20240
12 20240
13 20232
14 20228
15 20224
16 20223
17
Analysis of liver infiltrating lymphocytes in primary sclerosing cholangitis by surface antigen and single cell RNA sequencing using fine needle aspiration of the liver
20191
18 201913
19 20191
20 20181

About Kate D. Lynch

Kate D. Lynch is a scholar working on Hepatology, Epidemiology and Genetics, having authored 23 papers that have together received 123 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (10 papers), Liver Diseases and Immunity (10 papers), Microscopic Colitis (8 papers), Liver Disease Diagnosis and Treatment (6 papers), Gallbladder and Bile Duct Disorders (4 papers), Pediatric Hepatobiliary Diseases and Treatments (3 papers), SARS-CoV-2 and COVID-19 Research (1 paper) and Drug Transport and Resistance Mechanisms (1 paper). The work is most often cited by research in Hepatology (56 citations), Epidemiology (70 citations) and Pharmacology (11 citations). Kate D. Lynch has collaborated with scholars based in Australia, United Kingdom and New Zealand. Frequent co-authors include Roger W. Chapman, Satish Keshav, Robert V. Bryant, Jane M. Andrews, Samuel P. Costello, Charlotte Goess, Emmanuel Selvaraj, Alessandra Geremia, Fay Probert and Daniel Radford‐Smith. Their work appears in journals such as Gastroenterology, The American Journal of Gastroenterology and Alimentary Pharmacology & Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026